Speakers

Jacqueline Bohn, MD is a gynecology oncology fellow at The University of Oklahoma. She completed her medical degree at the University of Utah and her residency training in Obstetrics & Gynecology at Oregon Health & Science University in Portland, Oregon. Her research interests include screening and prevention of HPV related diseases, cost-effectiveness, and healthcare for incarcerated populations.

Philip E. Castle, PhD, MPH, was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and, in conjunction with his training in the NCI’s Cancer Prevention Fellowship Program, a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle also rejoins the NCI as a senior investigator in the Division of Cancer Epidemiology and Genetics, focused on discovery, development, and evaluation/validation of new technologies for the prevention of cancer. His professional interests include health disparities, science and translation of cancer prevention strategies, cancer screening, health services research and delivery, epidemiology of HPV and cervical/anogenital cancers, international health, and evidence-based medicine. Dr. Castle is conducting research studies on cancer screening and prevention in Mozambique, Rwanda, and Taiwan as well as continuing his work with Kaiser Permanente Northern California.

Helen E. Cejtin, MD, MPH is an Associate Professor at Northwestern Feinberg School of Medicine and an OB/GYN generalist with extensive experience taking care of vulnerable populations with a primary focus on people living with HIV and on cervical cancer screening at John H. Stroger Hospital, the safety net hospital for Cook County, Illinois. Dr. Cejtin is the director of the Colposcopy Clinic, a high-volume clinic dedicated to the prevention of cervical cancer in at-risk populations.

David P. Chelmow, MD is the Leo J. Dunn Professor of Obstetrics and Gynecology at Virginia Commonwealth University and has served as chair of OB/GYN since 2010. He completed his MD at Yale University Medical School and Residency at UCSF. Dr. Chelmow was the 2021-2022 ASCCP President. He serves on the US Preventive Services Task Force. He is past chair of the Women’s Preventive Services Initiative Multidisciplinary Steering Committee.

Christine Conageski, MD is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine. She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.

Levi S. Downs, Jr, MD, MS, is a gynecologic oncologist with Health Partners Park Nicollet. Dr. Downs received his medical degree from the University Of Pittsburgh School Of Medicine in Pittsburgh, Pennsylvania. He did his residency in obstetrics and gynecology at Magee-Women’s Hospital at the University of Pittsburgh Medical Center. Dr. Downs completed a fellowship in gynecologic oncology at the University of Minnesota and has a Master of Science degree in clinical research from the University Of Minnesota School of Public Health. Dr. Downs began his career at the University of Minnesota Medical School where he served as Chief of Gynecologic Oncology, Women’s Cancer Program Director at the Masonic Cancer Center and retired from the University of Minnesota after serving as Chief Medical Officer of University of Minnesota Physicians and University of Minnesota Health. He is currently Medical Director for Gynecologic Oncology at Health Partners Health System and is proudly serving on the organization’s Health Equity, Inclusion and Anti-Racism Cabinet. Dr. Downs has served as principal investigator for numerous clinical trials investigating ovarian and cervical cancers, chemotherapy, and therapeutic and preventive approaches to HPV related diseases. Among his many awards, Dr. Downs was recipient of the Robert Wood Johnson Foundation's Harold Amos Faculty Development Award. Among other societies Dr. Downs is also a member of the Society of Gynecologic Oncologists and serves on the Executive Board of the ASCCP.

Mark H. Einstein, MD, MS is Professor and Chair of Obstetrics, Gynecology and Women's Health at Rutgers New Jersey Medical School. Dr. Einstein is a Gynecologic Oncologist who is an expert at identification and treatment of gynecologic malignancies. His primary research interests focus on the pathogenesis, therapy, and prevention of lower anogenital tract and gynecologic cancers. He leads numerous clinical efforts identifying unique targets and biomarkers for clinical risk of malignant transformation. He is also testing many novel drugs for cancer treatment. He has been an active leader for management guidelines and translating clinical trial and translational data for such organizations as the World Health Organization (WHO), American Cancer Society (ACS), Society of Gynecologic Oncology (SGO), American College of Obstetrics and Gynecology (ACOG), and Society of Lower Genital Tract Disease (ASCCP). He serves on the Boards for SGO and the ASCCP. He has served on numerous committees and leadership for the National Cancer Institute (NCI)-funded NRG Oncology group and AIDS Malignancy Consortium (AMC). Currently, he serves as a principal investigator on many multi-institutional clinical trials for gynecologic cancers in the US and Internationally. He has been funded for his research efforts by a number of organizations including the NCI, ACS, Foundation for Women's Cancers, and others.

Dr. Huma Farid is a generalist obstetrician gynecologist at the Beth Israel Deaconess Medical Center (BIDMC) and Co-director of the Lower Genital Tract Dysplasia (LGTD) Center at BIDMC. She graduated from Harvard Medical School and completed her residency at Brigham and Women's Hospital/Massachusetts General Hospital. She joined BIDMC and serves as the Associate Program Director for the obstetrics and gynecology residency and is the Director of the Colposcopy Clinic. She is an Assistant Professor in Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Her clinical interests focus on DES exposure and her teaching interests focus on simulation.

Michael Fitzsimmons, MD practiced orthopedic hand surgery at St. Joseph Mercy Hospital in Ypsilanti, Michigan for over 30 years. He completed his residency in Orthopedic Surgery in 1990 at the University of Michigan. He completed his hand surgery fellowship at Tampa General Hospital in 1991. He has a particular interest in skin grafts and flaps.

Lisa Flowers, MD, MPH,is a Professor in the Department of Obstetrics and Gynecology, Fellowship Director of the Lower Anogenital Screening and Treatment Fellowship, Director of the Colposcopy and Anoscopy clinics at the Grady Cancer Center of Excellence, Emory University Healthcare Systems, and the Ponce de Leon Center. She has been a clinical specialist and translational researcher in the screening, detection and treatment of HPV related precancers and cancer.  Dr. Flowers is the 2022-2023 ASCCP President.

Dr. Eric Ganz's area of specialization is the comprehensive care of women with lower-genital tract dysplasia and HPV, specifically anal dysplasia diagnosis and treatment. He is currently on faculty in the Department of OBGYN at Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School in Boston and is Co-director of the Lower Genital Tract Dysplasia (LGTD) Center at BIDMC. He is also the Medical Director of the BIDMC OBGYN Ambulatory Clinic in Boston. In 2021, he joined BIDMC after twenty-five years at Mount Sinai Morningside (MSM) and Mount Sinai West (MSW)/Icahn School of Medicine at Mount Sinai (ISMMS). During that time, he was Vice-Chair of Operations and Academic Affairs in the Department OBGYN (MSM/MSW/ISMMS) and the Director of the Anal Dysplasia Clinic at the Morningside and Samuels Clinics at ISMMS. Dr. Ganz received his bachelor's degree from Duke University and his medical degree from Tufts University School of Medicine. He received residency training in obstetrics and gynecology at Thomas Jefferson University Hospital in Philadelphia.

Francisco Garcia, MD, MPH is the Deputy County Administrator & Chief Medical Officer, Health and Community Services for Pima County in Arizona. He is currently a member of the ASCCP Executive Committee.

Michael Gold, MD is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma School of Community Medicine. Dr. Gold specializes in gynecologic oncology and pelvic surgery. Dr. Gold received his medical degree from Jefferson Medical College in Philadelphia, PA. He completed his residency in gynecology and obstetrics at Thomas Jefferson University Hospital, also in Philadelphia. After residency, Dr. Gold completed his three-year fellowship in gynecologic oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, where he remained on the faculty for nine years. He then moved to Vanderbilt University Medical Center, where he was the Director of the Division of Gynecologic Oncology. Dr. Gold’s clinical interests include the prevention and treatment of cervical cancer and pre-cancer (dysplasia) of the cervix, vagina, and vulva. He is active in clinical research focusing on gynecologic cancers in general and the imaging of cervical and uterine cancer, in particular. Dr. Gold is board certified by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology. Dr. Gold is a Fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons. He is an active member of the Gynecologic Oncology Group, the Society of Gynecologic Oncologists, the American Society of Colposcopy and Cervical Pathology, and the American College of Radiology Imaging Network. Dr. Gold is an ASCCP past president.

Patti E. Gravitt, PhD, MS is a molecular epidemiologist and implementation scientist whose research in HPV and cervical cancer spans the translational spectrum from natural history of cervical HPV across the lifespan to translation of evidence-based prevention tools to low- and middle-income countries. Dr. Gravitt has conducted several studies to clarify the role of HPV latency, diagnostic misclassification, cohort effects, and hysterectomy correction of cervical cancer incidence and mortality rates on the accuracy of our concept of cervical cancer risk in post-menopausal women. After nearly 20 years in academia, Dr. Gravitt joined the NCI in 2021 as Deputy Director for the Center for Global Health, where she leads implementation science efforts and provides scientific and programmatic direction across CGH's research, training, partnership, and dissemination goals.

Richard S. Guido, MD is a Professor, Department of Obstetrics, Gynecology and Reproductive Sciences with the University of Pittsburgh. He served as Chair of the 2019 ASCCP Risk-Based Management Consensus Guidelines, and is a past president of ASCCP. He earned his MD from the University of Rochester.

Hope K. Haefner, MD, is the Harold A. Furlong Professor of Women’s Health in the Department of Obstetrics and Gynecology at the University of Michigan Hospitals in Ann Arbor, Michigan where she received her medical degree. Dr. Haefner completed her obstetrics and gynecology residency at the University of Michigan Medical Center in 1990. She completed a fellowship in gynecologic pathology in 1993. Dr. Haefner is board certified in obstetrics and gynecology. She opened the University of Michigan Center for Vulvar Diseases in 1993. It is one of a few clinics in the United States that specializes in treating these conditions. She has a national and international reputation in this field. She is a specialist in vulvoscopy. She has a particular interest in high grade squamous intraepithelial lesions of the vulva, lichen sclerosus, lichen planus and hidradenitis suppurativa (including skin grafts and flaps for patients with Stage 3 hidradenitis suppurativa). She is the primary author of the Vulvodynia Guideline, published in 2005. Dr. Haefner is active in vulvovaginal disease research. She was a co-investigator on a R01 with Dr. Barbara Reed, the Longitudinal Population-Based Study of Vulvodynia. Dr. Haefner is Past President of ASCCP.

Warner K. Huh, MD is Professor, Vice Chair of Gynecology, Director of the Division of Gynecologic Oncology, and the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB), Professor in the Department of Surgery, and Professor in the Department of Epidemiology in the UAB School of Public Health, and Senior Medical Officer and Senior Scientist in the UAB Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 225 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 47). He serves as co-PI of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program (2P50CA098252-06A1). Dr. Huh serves on the editorial boards of Gynecologic Oncology and The Journal of Lower Genital Tract Disease. He is a Past President of ASCCP. Dr. Huh has also served on the Board of Directors for the Society of Gynecologic Oncology (SGO).

Michelle J. Khan, MD, MPH, is a board-certified obstetrician gynecologist with fellowship training in Reproductive Infectious Diseases. She is a Clinical Associate Professor at Stanford University School of Medicine. She works as a generalist seeing patients for routine Ob/Gyn care, pregnancy and delivery, and in subspecialty clinics focused on HPV-related diseases of the anogenital tract. She founded the PEACH Program at Stanford, which is a clinical program devoted to Prevention and Education of Anogenital Cancers and human papillomavirus (HPV)-associated diseases. She sees patients of any gender and is a faculty member in the Stanford LGBTQ+ Health Program. She is active in professional societies teaching national and international courses in colposcopy and high-resolution anoscopy and formulating guidelines for screening and management of HPV-related diseases. She serves as the Secretary on the Executive Board for the American Society for Colposcopy and Cervical Pathology, as a member of the National Medical Committee of the Planned Parenthood Federation of America, and as the Co-Chair of the Education Task Force for the International Anal Neoplasia Society. She is also active in Diversity Equity and Inclusion including serving as Co-Director on the Stanford Department of Obstetrics and Gynecology DEI Committee and as a DEI committee member for the Infectious Diseases Society of Obstetricians and Gynecologists.

Aimée R. Kreimer, PhD, is a Senior Investigator at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics. She focuses her research on the etiology and prevention of human papillomavirus (HPV) and cancers at multiple sites, including the head and neck and anogenital region. She has particular interests in translational research, cancer etiology related to the natural history of HPV infection at multiple anatomic sites, and cancer prevention. She is an an expert in HPV vaccine and is the Principle Investigator on several prophylactic HPV vaccine trials including “ESCUDDO: A Randomized Trial of One-Dose HPV Vaccination,” a research initiative of the Cancer Moonshot.

Lindsay Kuroki, MD, MSCI, is a Assistant Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine. She received her MD from Brown University in 2009. She is currently on the Board of Directors for ASCCP.

Megan Lander, MD, is a fourth-year resident at Johns Hopkins University.

Dr. L. Stewart Massad led the writing group for the update to the 2017 ASCCP Colposcopy Standards on ECC at colposcopy. He is a professor in the Division of Gynecologic Oncology at Washington University in St. Louis.

E.J. Mayeaux, Jr., MD, DABFP, DABPM-CI, FAAFP, is a Professor of Family Medicine, Associate Vice Chancellor for Clinical Affairs, and Senior Associate Dean for Education and Administration at LSU Health Sciences Center in Shreveport, Louisiana, USA. He is board certified in Family Medicine and Preventive Medicine–Clinical Informatics. Dr. Mayeaux has been an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and the International Federation for Colposcopy and Pathology of the Cervix (IFCPC) since 1996. He is currently on the executive board of IFCPC and was ASCCP President in 2014. He serves on a number of committees including the International Education & Humanitarian Outreach Committee. He was the lead editor of Modern Colposcopy, 3rd edition, the flagship publication on colposcopy from the ASCCP. Dr. Mayeaux has published and edited 9 books including The Color Atlas of Family Medicine and The Essential Guide to Primary Care Procedures, both of which are available in multiple languages. He regularly lectures all over the world on a variety of women's health, skin diseases, leadership, and primary care topics.Dr. Mayeaux’s clinical expertise includes women’s health topics such as cervical disease, HPV disease, HPV vaccination, skin diseases and patient literacy as it relates to clinical medicine. He also speaks regularly on leadership topics, population health, disparities in healthcare, skin diseases, skin surgery, medical burnout, joy in medicine, and other topics. He has dedicated the greatest part of his professional life to the study and practice of women's health.

Dr. Sara McKinney is an OBGYN general physician at Beth Israel Deaconess Medical Center (BIDMC), where she is Co-director of the Lower Genital Tract Dysplasia (LGTD) Center and the director of the Vulvovaginal Clinic. Dr. McKinney became a fellow of the International Society of the Study for Vulvovaginal Disease (ISSVD) in 2022, is a member of their Education Committee, and is actively involved in advancing medical and resident education in vulvovaginal curriculum. She is an instructor at Harvard Medical School and a 2020 recipient of the Eleanor and Miles Shore Faculty Development Award, which enabled her to establish a novel vulvovaginal curriculum for resident physicians. She is also on the medical advisory board of Tight Lipped, a grassroots campaign that advocates for people with chronic vulvovaginal and pelvic pain. She received her Bachelor of Arts from Scripps College in Claremont, California, medical degree from the University of California Davis School of Medicine, and did her OBGYN residency training at BIDMC.

Anna-Barbara Moscicki, MD, is Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine, and Associate Vice Chair of Clinical Research, Department of Pediatric. Dr. Moscicki is Past President for the ASCCP. Dr. Moscicki’s career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. Dr. Moscicki has been the principle investigator of a natural history study of HPV in adolescents and young women since 1990, one of the longest running HPV cohorts. Her work was highly influential in forming the new cervical cancer screening guidelines and triage of abnormal cytology in young women. Her recent work focuses on mucosal immunology and the vaginal microbiota. She has been involved in numerous clinical trials including vaginal microbiocides and an ongoing one dose HPV vaccine trial. She is also involved in health outcomes in perinatally HIV infected children including HPV vaccine efficacy, sexual risk behaviors, substance use, oral health, microbiomes, and HPV infections and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS. She has over 150 publications and she serves on numerous national and international committees, including the W.H.O., N.I.H., ASCCP, and the American Cancer Society.

Akiva P. Novetsky, MD, MS, is an Associate Professor in the Department of Obstetrics and Gynecology at Westchester Medical Center/New York Medical College. He also serves as the Associate Chair of the Department of Obstetrics and Gynecology for Quality and Safety. Dr. Novetsky obtained his bachelor’s degree in Biology from Yeshiva University and a medical degree from Albert Einstein College of Medicine. He is board certified in Obstetrics and Gynecology with subspecialty certification in Gynecologic Oncology. Dr. Novetsky is an active member of the the American Society for Colposcopy and Cervical Pathology (ASCCP) and serves as a Member-at-Large on the ASCCP Board of Directors. He was the Chair of the 2020, 2021 and 2022 Annual Scientific meetings. Additionally, he has served as past Chair of the ASCCP Assessment Committee and continues to serve as a member of the Education and Finance committees. He is an associate editor for the Journal of Lower Genital Tract Disease and serves as a reviewer for multiple other journals. Dr. Novetsky served on the working groups that developed the Colposcopy Standards guidelines, published in 2017 and on the working group and steering committee for the development of the 2019 Management Guidelines. He also serves as a co-chair of one of the working groups in the American Cancer Society initiative to transition to Primary HPV screening. Dr. Novetsky’s clinical expertise includes women’s cancers including: cervical, uterine, ovarian, vulvar and vaginal cancers as well as the pre-malignant conditions associated with these diseases.

Joel M. Palefsky, MD, is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV). Dr. Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments. He earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University. Dr. Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.

Nancy Phillips, MD, is a Board-certified obstetrician/gynecologist, Associate Professor and Director of the Center for Vulvovaginal Health in the Department of Obstetrics, Gynecology & Reproductive Science at Rutgers-Robert Wood Johnson Medical School in New Brunswick, New Jersey. Dr Phillips’ clinical interest is in vulvovaginal health, with an emphasis on vulvodynia. Other areas of interest include menopause, hormone therapy and pelvic pain. She has authored and co-authored many peer-reviewed articles and book chapters in these fields, including an on-line Prologue teaching review for the American College of Obstetrics and Gynecology and a Position Statement for the International Society for the Study of Vulvovaginal Disease on Vulvovaginal atrophy. Dr. Phillips is also involved in clinical research in areas of vulvodynia, vulvovaginal atrophy, menopausal hot flushes, and the vaginal microbiome. She serves on the Rutgers-Robert Wood Johnson Internal Review Board for clinical research, and is a reviewer for UptoDate and several journals, including the Journal for Sexual Medicine and the American Journal of Obstetrics and Gynecology. She is Senior Editorial Advisor for the online journal Case Reports in Women's Health. Nancy Phillips completed a Residency in Obstetrics and Gynecology at George Washington University, Washington, DC, (1992); a Medical Degree from Rutgers-Robert Wood Johnson Medical School (1988) and a Bachelor of Science (summa cum laude) from Villanova University (1984).

Michael L. Pirics, MD is a gynecologist in the Department of Obstetrics and Gynecology at Houston Methodist Hospital in Houston, Texas. Dr. Pirics received his medical degree from Baylor College of Medicine and then completed a residency in Obstetrics and Gynecology at Houston Methodist Hospital. After two years in private practice, he returned to join the faculty for the Obstetrics and Gynecology Residency at Houston Methodist Hospital and is an Adjunct Assistant Professor for Texas A&M School of Engineering Medicine. He serves as the course director for the Departmental Grand Rounds, Morbidity & Mortality, and Gynecology Journal Club. He is involved in pre-clinical education at Texas A&M, where he is course co-director for Endocrinology and Reproductive Medicine. He is also the Clinic Director for the Raymond H. Kaufman Dysplasia Clinic, where he instructs both Family Medicine as well as Obstetrics and Gynecology residents in HPV-related disease, colposcopy, and treatment.

Carolann Risley, Ph.D., WHNP-C, is an Associate Professor at the University of Mississippi Medical Center (UMMC) School of Nursing. She holds secondary appointments in the School of Medicine Department of Cell and Molecular Biology and the Cancer Center and Research Institute. In 1992, she earned a master's degree at the University of Pennsylvania and became certified as a women's health nurse practitioner. In 2019, she earned a Ph.D. at the UMMC School of Graduate Studies and went on to complete a postdoctoral fellowship in the National Cancer Institute's Clinical Genetics Branch. Currently, at the UMMC, she is a Mississippi Center for Clinical and Translational Research Scholar and is the PI of the STRIDES study, (Studying Risk to Improve DisparitiES in cervical cancer in Mississippi), a study co-led by investigators at the UMMC, the Mississippi Department of Health, and the National Cancer Institute. Additionally, she is leading efforts with the Centers for Disease Control and Prevention and the MITRE corporation to develop a clinical decision support tool for cervical cancer screening and management in the electronic medical record.

Vikrant Sahasrabuddhe, MPH, MBBS, DrPH is Deputy Chief of the Breast and Gynecologic Cancer Research Group and Program Director in the Division of Cancer Prevention at the National Cancer Institute overseeing prevention clinical research on cervical cancer and other human papillomavirus (HPV)-related cancers. Dr. Sahasrabuddhe provides scientific direction and strategic guidance for efforts on optimization of clinic-based and population-based precision prevention strategies for cervical cancer and other HPV-related cancers and building the evidence base for their implementation in the United States and globally.

Mila Pontremoli Salcedo, MD, PhD, is an Instructor and Director of Training & Education programs for cervical cancer prevention in Mozambique, Texas and other low-resource settings at The Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston/Texas. Dr. Salcedo is the co-Chair of Preinvasive Program at the International Gynecologic Cancer Society and the International Affairs Advisor for Teaching and Research at Santa Casa Hospital in Porto Alegre, Brazil. Dr. Salcedo served as an Associate Professor in the Department of Obstetrics and Gynecology at the Federal University of Health Sciences of Porto Alegre (UFCSPA)/Brazil, where she was the Director of the Gynecology and Obstetrics Department at UFCSPA and the Chair and Director of Gynecology at Santa Casa de Misericordia Hospital of Porto Alegre, Brazil. Her primary research interests are in HPV, cervical and vulvar cancer prevention, and lower genital tract disease, especially in low resource settings.

Debbie Saslow, PhD, is the Managing Director of HPV & GYN Cancers at the American Cancer Society where she has worked since 1997. Dr. Saslow serves as the ACS lead for HPV-related cancers and directs their HPV vaccination nationwide priority program of work, provides strategic direction and leads staff teams working on the implementation of HPV related activities, and provides evidenced-based guidance to the organization. She is responsible for developing and updating ACS guidelines, including guidelines for cervical cancer screening and for HPV vaccination. Dr. Saslow is also the Principal Investigator on two cooperative agreements to increase HPV vaccination, and serves as the Vice-Chair of the National HPV Vaccination Roundtable. Dr. Saslow received her undergraduate degree in biology with honors from Brown University, her PhD in human and molecular genetics from Yale University, and completed a post-doctoral fellowship at the National Cancer Institutes’ Laboratory of Pathology in Women’s Cancers.

Peter F. Schnatz, DO, MBA, FACOG, FACP, NCMP, is the Associate Chairman and Residency Program Director in the Dept of ObGyn at The Reading Hospital in PA. Dr. Schnatz is an Internist and ObGyn and is a Professor at Drexel University. Dr. Schnatz is a Past President of the North American Menopause Society (NAMS) and the Philadelphia ObGyn Society. He is on the Board of Advisors to The Advancing Health After Hysterectomy Foundation, Inc. and is on a number of Editorial Boards. Dr. Schnatz is a regular faculty member for ASCCP courses, is a past Chair of the ASCCP education committee, and is on the ASCCP Board of Directors. He is a past CREOG Region II Program Director’s Representative to the CREOG Council as well as a number of ACOG committees, is an ABOG oral board examiner, and a reviewer for multiple journals. He is an editorial Board member for SASGOG’s Pearls of Excellence, is the Vice Chair – Pearls Publications Committee, and is the Editor-in-Chief of SASGOG’s newest book. He currently serves as the Chair of the Education Committee for the International Menopause Society (IMS). Dr. Schnatz is the Founder, Chairman of the Board, and CEO of FaithCare, Incorporated, an organization involved in humanitarian aid both locally and internationally. Schnatz is a NAMS Certified Menopause Practitioner and is actively involved as both a clinician and a researcher. Dr. Schnatz has well over 200 publications, with at least 140 of those as peer reviewed medical articles and many award-winning papers and/or presentations. Dr Schnatz graduated from the Rowan University School of Osteopathic Medicine and completed his Internal Medicine and ObGyn residencies at UConn, in Farmington, CT.

Riddhimaa Sinha is a senior at Rutgers University, pursuing a departmental honors through the department of Biological Sciences. She has fueled her research interests through both clinical and laboratory projects and spending her summers interning with Boston University School Of Medicine and Massachusetts General Hospital. At Rutgers University, she is an intern at the Women's Health Institute and a research assistant in the department of neurosurgery. Upon receiving her bachelors, she wishes to pursue clinical research as she prepares to apply to medical schools.

Elizabeth Stier, MD is a professor at Boston University School of Medicine. Dr. Stier is a gynecologist, clinician-researcher, working towards cervical, anal, and vulva cancer prevention especially for people living with HIV. Dr. Stier is chair of the HPV Working Group of the AIDS Malignancy Consortium and a member of the CDC-sponsored HPV disease committee, Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents.

Colleen K. Stockdale, MD, MS, is a Clinical Professor of Obstetrics and Gynecology at the University of Iowa. She is the Director of the Colposcopy and Vulvar Vaginal Disease Clinics. Dr. Stockdale is a Past President of ASCCP.

Megan Swanson, MD is a gynecologic oncologist who cares for women with cervical, vulvar, uterine and ovarian cancers, as well as women with cervical dysplasia. Her expertise encompasses both surgical and medical care. Dr. Swanson’s research focuses on cervical cancer, particularly the striking disparities in access to care and in outcomes between women in high-income countries and those in low- to middle-income countries, as well as in the availability of effective screening and prevention methods. She has worked on identifying barriers and facilitators to cervical cancer screening and care in East Africa, and is currently developing innovative pilot projects in Uganda to increase screening and treatment opportunities. Dr. Swanson earned a master of public health degree at the University of California, Berkeley and her medical degree at UCSF. She completed a residency in obstetrics and gynecology at UCSF. She completed a fellowship in gynecologic oncology at UCSF and Kaiser Permanente. While completing this fellowship, she was awarded a GloCal Health Fellowship from the Fogarty International Center of the National Institutes of Health. This allowed her to spend a year in Kampala, Uganda, working at Makerere University College of Health Sciences, Mulago National Referral Hospital and the Uganda Cancer Institute

Alan G. Waxman, MD, MPH, is Emeritus Professor of Obstetrics and Gynecology at the University of New Mexico (UNM) in Albuquerque, NM. He completed his medical degree and ob/gyn residency at the University of Colorado and his Masters of Public Health at Emory University. He joined the faculty of UNM in 2000 after completing a 24 year career with the Indian Health Service (IHS). Dr. Waxman’s principle area of interest since 1991 has been cervical cancer screening and prevention. He has been director of the IHS Colposcopy Courses annually since 1992. He served on numerous committees of ASCCP including 14 years on the Board of Directors and was the Society’s President 2012-2013. In 2018 he was awarded ASCCP’s Lifetime Achievement Award. He has lectured nationally and internationally on cervical cancer prevention, human papillomavirus and colposcopy. He has authored numerous articles and book chapters on colposcopy, cervical cancer screening, and related subjects. Dr. Waxman retired from clinical practice in 2020. He remains actively involved in numerous academic projects related to cervical cancer prevention, and continues to teach colposcopy throughout the U.S. and internationally.

Kathryn Welch, MD, is an Assistant Professor of Obstetrics and Gynecology at the University of Michigan. She is a Michigan native who earned her undergraduate degree at Michigan State University. Dr. Welch then pursued her medical degree at Wayne State University School of Medicine and completed her residency training in Obstetrics and Gynecology at Wayne State University/Detroit Medical Center. Her practice encompasses general obstetrics and gynecology, with a focus on vulvar diseases. Outside of work, Dr. Welch enjoys spending time with her husband, daughter and dog. Any spare time is spent relaxing at her family cottage.

Nicolas Wentzensen, MD, PhD, received an M.D. in 2000 and a Ph.D. in Applied Tumor Biology in 2007, both from the University of Heidelberg. He conducted research in molecular biology, molecular pathology, and molecular epidemiology at the Department of Surgery and at the Institute of Pathology, University of Heidelberg. He built a research group focusing on cervical cancer biomarker discovery and validation and established a diagnostic laboratory for cervical cancer screening. In 2009 he earned a Master of Science in Epidemiology from the University of Mainz. Dr. Wentzensen joined DCEG as a visiting fellow in 2007, became a tenure-track investigator in 2009, and was awarded scientific tenure by the NIH and appointed senior investigator in 2013. In 2015 he joined the Clinical Genetics Branch as Deputy Chief and head of the newly formed Clinical Epidemiology Unit (CEU) within CGB. Dr. Wentzensen’s research is focused on clinical epidemiology of gynecological cancers.

Amy Wiser, MD, FAAFP, IBCLC, (she/her) is a family medicine physician in Portland, Oregon. She works for Cascade AIDS Project at Prism Health, a primary care clinic focusing on LGBTQIA+ health and HIV medicine. After graduating from family medicine residency training in Pennsylvania, she completed her OB Fellowship through University of Washington in Spokane. She has practiced in rural Oregon and in academia, held surgical privileges at a university hospital for near a decade as one of few family doctors in the country to do so, and directed medical school curriculum before moving to her current position at a look-alike FQHC. She is also an international board certified lactation consultant. Dr. Wiser is on the Board of Directors of the ASCCP and has traveled internationally teaching with ASCCP, held position of Co-Director of the Comprehensive Colposcopy Course, contributed to the 2019 ASCCP Risk-Based Management Consensus Guidelines, and serves on the American Cancer Society Primary HPV Screening Initiative and the Steering Committee of the National Roundtable on Cervical Cancer (NRTCC).